Psychological Impacts of Male Sexual Dysfunction in Pelvic Cancer Survivorship.


Journal

Sexual medicine reviews
ISSN: 2050-0521
Titre abrégé: Sex Med Rev
Pays: Netherlands
ID NLM: 101614773

Informations de publication

Date de publication:
10 2019
Historique:
received: 18 12 2018
revised: 04 02 2019
accepted: 09 02 2019
pubmed: 31 3 2019
medline: 2 5 2020
entrez: 31 3 2019
Statut: ppublish

Résumé

A common negative sequela of cancer treatment in men is sexual dysfunction, which can have a significant psychological impact and can contribute to feelings of depression, anxiety, and other mental health issues. Management of cancer survivors' psychological and mental well-being plays an important role in the treatment and recovery process. To identify how sexual dysfunction impacts the lives of male cancer survivors and to provide clinicians with treatment recommendations specific to this patient population. A total of 51 peer-reviewed publications related to sexual dysfunction in male cancer survivors were selected for analysis. Sources were chosen based on relevance to current cancer therapies, causes and psychological impacts of sexual dysfunction, and treatment recommendations for clinicians caring for cancer survivors. PubMed search terms included "sexual dysfunction," "cancer survivorship," and "male cancer survivors." Measures of sexual dysfunction were based on cancer survivors reporting inadequate erectile capacity for penetrative sexual intercourse, decreased sensitivity of the genitalia, or inability to enjoy sex. Sexual dysfunction was present in male cancer survivors from diverse ages, cancer diagnoses, and treatments of cancer. Many of the men surveyed presented with psychological distress resulting from their posttreatment sexual dysfunction. This had a significant negative impact on their sexual self-esteem, body image, and mental health. Sexual and social development was delayed in survivors of childhood cancer. Healthcare practitioners should initiate conversations with patients regarding the potential for sexual dysfunction at the time of cancer diagnosis and throughout treatment and follow-up. Physical symptoms of sexual dysfunction should be treated, whenever possible, using phosphodiesterase 5 inhibitors or other interventions, and all cancer survivors presenting with psychological distress related to sexual dysfunction should be offered professional counseling. Twitchell DK, Wittmann DA, Hotaling JM, et al. Psychological Impacts of Male Sexual Dysfunction in Pelvic Cancer Survivorship. Sex Med Rev 2019;7:614-626.

Identifiants

pubmed: 30926459
pii: S2050-0521(19)30010-1
doi: 10.1016/j.sxmr.2019.02.003
pmc: PMC6763375
mid: NIHMS1522576
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

614-626

Subventions

Organisme : NIDDK NIH HHS
ID : K08 DK115835
Pays : United States
Organisme : NIDDK NIH HHS
ID : T35 DK103596
Pays : United States

Informations de copyright

Copyright © 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Références

Sex Med Rev. 2018 Apr;6(2):242-252
pubmed: 28923561
J Clin Oncol. 2018 Feb 10;36(5):492-511
pubmed: 29227723
J Sex Med. 2010 Apr;7(4 Pt 2):1668-86
pubmed: 20388164
Psychooncology. 2005 Mar;14(3):227-38
pubmed: 15386772
Eur Urol. 2014 Mar;65(3):587-96
pubmed: 24169081
Cancer Nurs. 2009 Mar-Apr;32(2):E1-7
pubmed: 19258822
BMJ. 2009 Nov 27;339:b4817
pubmed: 19945997
Pediatr Blood Cancer. 2016 Sep;63(9):1622-8
pubmed: 27163396
BMC Med. 2014 Oct 20;12:185
pubmed: 25330139
Med Pediatr Oncol. 1999 Jul;33(1):2-8
pubmed: 10401490
Int J Cancer. 2005 Aug 20;116(2):291-6
pubmed: 15800919
Nat Rev Urol. 2015 Mar;12(3):167-76
pubmed: 25753250
J Sex Med. 2013 Aug;10(8):2084-93
pubmed: 23679087
J Sex Med. 2011 Feb;8(2):560-6
pubmed: 21155979
Sex Med Rev. 2018 Jul;6(3):396-409
pubmed: 29396283
Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):33-9
pubmed: 7721637
Mayo Clin Proc. 2012 Aug;87(8):766-78
pubmed: 22862865
J Sex Med. 2014 Sep;11(9):2318-26
pubmed: 24995845
JAMA Intern Med. 2014 Jun;174(6):964-70
pubmed: 24710960
Urology. 2005 Dec;66(6):1292-5
pubmed: 16360459
JAMA. 2003 Sep 24;290(12):1583-92
pubmed: 14506117
J Sex Med. 2015 Feb;12(2):494-504
pubmed: 25358901
Pediatr Blood Cancer. 2008 Mar;50(3):594-8
pubmed: 17514733
J Urol. 2011 Feb;185(2):614-8
pubmed: 21168870
Vasc Health Risk Manag. 2012;8:517-23
pubmed: 22973106
BJU Int. 2013 Apr;111(4):658-65
pubmed: 23186312
Psychooncology. 2017 Sep;26(9):1336-1346
pubmed: 27197037
Urology. 2006 Dec;68(6):1224-9
pubmed: 17141840
Psychooncology. 2012 Jun;21(6):594-601
pubmed: 21394821
Arch Sex Behav. 2017 Oct;46(7):2043-2057
pubmed: 27102603
Ann Intern Med. 2009 Nov 3;151(9):650-61
pubmed: 19884626
Curr Pharm Des. 2015;21(11):1440-54
pubmed: 25354178
Pediatr Blood Cancer. 2007 Oct 15;49(5):716-22
pubmed: 17096410
Neuropsychiatr Dis Treat. 2013;9:1273-80
pubmed: 24039429
J Sex Med. 2018 Dec;15(12):1785-1791
pubmed: 30527054
J Sex Med. 2016 Jan;13(1):70-8
pubmed: 26755089
J Sex Med. 2016 Apr;13(4):489-518
pubmed: 27045255
Patient Educ Couns. 2016 Dec;99(12):2049-2054
pubmed: 27439668
Int J Clin Pract. 2010 Jan;64(2):240-55
pubmed: 19900167
J Sex Med. 2012 Oct;9(10):2724-32
pubmed: 22989267
BJU Int. 2007 Jan;99(1):33-6
pubmed: 17034492
BMC Urol. 2017 Jun 15;17(1):45
pubmed: 28619019
J Sex Med. 2016 Apr;13(4):519-37
pubmed: 27045256
Mil Med. 2019 May 1;184(5-6):e330-e337
pubmed: 30535336
J Urol. 2018 May;199(5):1202-1209
pubmed: 29253578
Eur J Endocrinol. 2018 Jul;179(1):21-29
pubmed: 29712718
Sex Med. 2014 Aug;2(3):141-51
pubmed: 25356311
Curr Urol Rep. 2013 Oct;14(5):511-7
pubmed: 23907555
J Urol. 2008 May;179(5 Suppl):S40-4
pubmed: 18405749
PLoS Med. 2016 Jun 14;13(6):e1002037
pubmed: 27299522
J Sex Med. 2016 Mar;13(3):425-34
pubmed: 26853048
Acta Oncol. 2017 Jan;56(1):17-20
pubmed: 27420031
J Urol. 2004 Apr;171(4):1611-4
pubmed: 15017233
JAMA. 2015 Jun 23-30;313(24):2449-55
pubmed: 26103029
Sex Med Rev. 2017 Oct;5(4):429-433
pubmed: 28642048
J Sex Med. 2018 Oct;15(10):1478-1490
pubmed: 30297094
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):126-32
pubmed: 19362236
Psychooncology. 2008 May;17(5):506-11
pubmed: 17935145
J Am Osteopath Assoc. 2004 Mar;104(3 Suppl 4):S11-5
pubmed: 15083994
Reprod Biomed Online. 2013 Sep;27(3):261-70
pubmed: 23871365
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):30-8
pubmed: 18538503
Andrologia. 2016 May;48(4):425-30
pubmed: 26268684
J Sex Med. 2015 Nov;12 Suppl 7:415-21
pubmed: 26565568

Auteurs

David K Twitchell (DK)

University of Utah School of Medicine, Salt Lake City, UT, USA.

Daniela A Wittmann (DA)

Department of Urology, University of Michigan, Ann Arbor, MI, USA.

James M Hotaling (JM)

Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.

Alexander W Pastuszak (AW)

Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address: alexander.pastuszak@hsc.utah.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH